X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (66) 66
Conference Proceeding (6) 6
Book Review (4) 4
Publication (4) 4
Book Chapter (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
index medicus (29) 29
oncology (21) 21
male (20) 20
melanoma (20) 20
middle aged (18) 18
female (16) 16
adult (15) 15
aged (15) 15
melanoma - drug therapy (13) 13
metastatic melanoma (13) 13
melanoma - pathology (12) 12
dermatology (11) 11
cancer (10) 10
skin neoplasms - drug therapy (10) 10
skin neoplasms - pathology (10) 10
metastasis (9) 9
aged, 80 and over (8) 8
ipilimumab (8) 8
melanoma - secondary (8) 8
analysis (5) 5
antibodies, monoclonal - adverse effects (5) 5
antineoplastic agents - adverse effects (5) 5
chemotherapy (5) 5
immunotherapy (5) 5
malignant-melanoma (5) 5
prognosis (5) 5
survival (5) 5
antibodies, monoclonal - therapeutic use (4) 4
antineoplastic agents - therapeutic use (4) 4
breast-cancer (4) 4
care and treatment (4) 4
endocrinology & metabolism (4) 4
hematology, oncology and palliative medicine (4) 4
medicine & public health (4) 4
melanoma - immunology (4) 4
neoplasm staging (4) 4
nivolumab (4) 4
patients (4) 4
skin cancer (4) 4
skin neoplasms - diagnosis (4) 4
trial (4) 4
antibodies, monoclonal - immunology (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - immunology (3) 3
biopsy (3) 3
follow-up studies (3) 3
germany - epidemiology (3) 3
interferon-alpha - therapeutic use (3) 3
lactate-dehydrogenase (3) 3
lymphocyte-associated antigen-4 (3) 3
malignant melanoma (3) 3
melanoma - diagnosis (3) 3
melanoma - metabolism (3) 3
melanoma - therapy (3) 3
mutation (3) 3
pembrolizumab (3) 3
psychiatry (3) 3
retrospective studies (3) 3
side effects (3) 3
skin - drug effects (3) 3
skin neoplasms - metabolism (3) 3
survival rate (3) 3
untreated melanoma (3) 3
610 medicine & health (2) 2
abridged index medicus (2) 2
adjuvante therapie (2) 2
alternative medicine (2) 2
american joint committee (2) 2
antigens (2) 2
antigens, cd - immunology (2) 2
antineoplastic agents (2) 2
apoptosis (2) 2
article (2) 2
bleomycin (2) 2
blockade (2) 2
bmi (2) 2
braf-inhibitoren (2) 2
brain (2) 2
catalysis (2) 2
catalysts (2) 2
cell biology (2) 2
cell cycle checkpoints - immunology (2) 2
cell line, tumor (2) 2
cell lung-cancer (2) 2
chemical and drug induced liver injury - immunology (2) 2
chronic hepatitis-c (2) 2
cohort studies (2) 2
complementary and alternative medicine (2) 2
complementary therapies - methods (2) 2
complications and side effects (2) 2
comprehensive cancer center (2) 2
consequences (2) 2
ctla-4 antibody (2) 2
ctla-4 antigen (2) 2
ctla-4 antigen - antagonists & inhibitors (2) 2
ctla-4 antigen - immunology (2) 2
ctla-4 blockade (2) 2
cutaneous melanoma (2) 2
cytotoxicity (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JDDG - Journal of the German Society of Dermatology, ISSN 1610-0379, 04/2011, Volume 9, Issue 4, pp. 277 - 286
Journal Article
HAUTARZT, ISSN 0017-8470, 04/2019, Volume 70, Issue Suppl 1, pp. 72 - 74
Journal Article
Im Focus Onkologie, ISSN 1435-7402, 11/2017, Volume 20, Issue 11, pp. 39 - 42
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, pp. e53745 - e53745
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces... 
TRIAL | CTLA-4 BLOCKADE | INDUCED SARCOIDOSIS | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | AUTOIMMUNE-DISEASES | PHASE-I/II | MULTIDISCIPLINARY SCIENCES | TREMELIMUMAB CP-675,206 | MONOCLONAL-ANTIBODY | PATIENT | CANCER | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Neoplasm Metastasis | Liver - drug effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Endocrine System - drug effects | Adult | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Kidney - drug effects | Antineoplastic Agents - immunology | Pancreas - drug effects | Gastrointestinal Tract - drug effects | Melanoma - pathology | CTLA-4 Antigen - immunology | Nervous System - drug effects | Melanoma - drug therapy | Respiratory System - drug effects | Aged | Skin - drug effects | Antimitotic agents | Antigens | Care and treatment | Algorithms | Lymphocytes | Melanoma | Skin | Metastasis | Antineoplastic agents | Skin cancer | Cancer | Aseptic meningitis | Guillain-Barre syndrome | Exanthema | Central nervous system | Blocking antibodies | Cytotoxicity | Oncology | Lymphocytes T | Metastases | CTLA-4 protein | Intestine | Gastroenterology | Meningitis | Internal medicine | Hematology | Sarcoidosis | Dermatology | Management | Regression analysis | Patients | Eosinophilia | Morbidity | Inflammatory bowel disease | Pathology | Side effects | Hospitals | Perforations | Medical prognosis | Antitumor activity | Autoimmune diseases | Endocrinology | Index Medicus
Journal Article
Science, ISSN 0036-8075, 10/2015, Volume 350, Issue 6257, pp. 207 - 211
Journal Article
JDDG - Journal of the German Society of Dermatology, ISSN 1610-0379, 11/2013, Volume 11, Issue 11, pp. 1041 - 1047
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 10/2014, Volume 12, Issue 10, pp. 906 - 907
Journal Article
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 10/2014, Volume 12, Issue 10, pp. 906 - 907
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 10/2014, Volume 12, Issue 10, pp. 906 - 907
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.